• He Junli, CEO, raised his Harvard Apparatus Regenerative Technology stake to 1,332,930 common shares.
• Position increase included 683,725 shares received at $1.05 via conversion of bridge notes into common stock.
• He also bought 361,905 shares at $1.05 in a private placement, then added 6,725 shares at $2.15.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harvard Apparatus Regenerative Technology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-031181), on September 25, 2026, and is solely responsible for the information contained therein.